158 related articles for article (PubMed ID: 25103530)
1. A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin.
Zhang Y; Zhang Q; Fan Z; Sun J; Liu X; Cheng L; Li A; Xu J
Pathol Oncol Res; 2015 Apr; 21(2):389-97. PubMed ID: 25103530
[TBL] [Abstract][Full Text] [Related]
2. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
3. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
[TBL] [Abstract][Full Text] [Related]
4. Chang-wei-qing, a Chinese herbal formula, ameliorates colitis-associated tumour development via inhibiting NF-κB and STAT3 signalling pathway.
Wan G; Xie M; Zhang X; Li M
Pharm Biol; 2019 Dec; 57(1):231-237. PubMed ID: 30905249
[TBL] [Abstract][Full Text] [Related]
5. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
[TBL] [Abstract][Full Text] [Related]
7. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
[TBL] [Abstract][Full Text] [Related]
8. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
[TBL] [Abstract][Full Text] [Related]
9. β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through ΔNP73 Negative Regulation in Colon Cancer.
San Millán C; Soldevilla B; Martín P; Gil-Calderón B; Compte M; Pérez-Sacristán B; Donoso E; Peña C; Romero J; Granado-Lorencio F; Bonilla F; Domínguez G
Clin Cancer Res; 2015 Oct; 21(19):4398-409. PubMed ID: 26023082
[TBL] [Abstract][Full Text] [Related]
10. γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells.
Song L; Du A; Xiong Y; Jiang J; Zhang Y; Tian Z; Yan H
Tumour Biol; 2016 Nov; 37(11):14885-14894. PubMed ID: 27644246
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Biochem Pharmacol; 2015 May; 95(1):28-37. PubMed ID: 25801007
[TBL] [Abstract][Full Text] [Related]
12. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Ning Y; Labonte MJ; Zhang W; Bohanes PO; Gerger A; Yang D; Benhaim L; Paez D; Rosenberg DO; Nagulapalli Venkata KC; Louie SG; Petasis NA; Ladner RD; Lenz HJ
Mol Cancer Ther; 2012 Jun; 11(6):1353-64. PubMed ID: 22391039
[TBL] [Abstract][Full Text] [Related]
13. Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway.
Liu H; Liu H; Zhou Z; Parise RA; Chu E; Schmitz JC
Cell Commun Signal; 2018 Feb; 16(1):7. PubMed ID: 29458395
[TBL] [Abstract][Full Text] [Related]
14. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
15. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
16. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
[TBL] [Abstract][Full Text] [Related]
17. A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.
Abu Ammar A; Raveendran R; Gibson D; Nassar T; Benita S
J Med Chem; 2016 Oct; 59(19):9035-9046. PubMed ID: 27603506
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.
Chang S; Yang J; Chen W; Xie Y; Sheng W
Mol Biol Rep; 2011 Jan; 38(1):395-401. PubMed ID: 20354907
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of nimesulide and oxaliplatin on tumor growth and lymphatic metastasis of transplanted human lung cancer in nude mice].
Lang Z; Chen G; Wang DC
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):739-44. PubMed ID: 23291066
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.
Leonetti C; Scarsella M; Zupi G; Zoli W; Amadori D; Medri L; Fabbri F; Rosetti M; Ulivi P; Cecconetto L; Bolla M; Tesei A
Mol Cancer Ther; 2006 Apr; 5(4):919-26. PubMed ID: 16648562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
